logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (vi) Distribution of new inpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids0.015.945.256.650.046.943.919.030785
Cocaine0.02.54.15.58.87.05.61.93660
Stimulants2.221.018.811.99.513.19.49.0106514
Hypnotics and sedatives6.76.25.08.617.020.026.753.21024151
Hallucinogens3.31.10.50.30.10.00.00.0310
Volatile substances23.310.43.41.90.60.80.60.92544
Cannabis 33.335.621.613.211.29.37.85.813060
Other substances 31.17.41.52.02.83.06.110.23052
Total9011641842172310236593605687429176

Notes:

 The countries supplying data are: 

 BG, CZ, DK, IE, GR, CY, HU, RO, SK, FI, SE, UK, TR 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-104- New inpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI inpatient treatment centres. 

Page last updated: Monday, 12 November 2007